Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
61.10 BKRW
1950KRW
29.77 BKRW
230.39 BKRW
8.13 M
About WHANIN PHARM
Sector
Headquarters
Seoul
Employees (FY)
645
Website
Founded
1978
ISIN
KR7016580003
FIGI
BBG000H0NTK9
Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. Its products include psychotropic agent, medicine for circulating system and digestive ulcers, therapeutic for osteoporosis, pain killers, and others. The company was founded by Kwang-Sik, Lee on June 5, 1978 is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 016580 is 13830 KRW — it has decreased by 0.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange WHANIN PHARM stocks are traded under the ticker 016580.
WHANIN PHARM is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
016580 stock is 1.02% volatile and has beta coefficient of 0.55. Check out the list of the most volatile stocks — is WHANIN PHARM there?
WHANIN PHARM revenue for the last quarter amounts to 58.80 B KRW despite the estimated figure of 56.00 B KRW. In the next quarter revenue is expected to reach 57.50 B KRW.
Yes, you can track WHANIN PHARM financials in yearly and quarterly reports right on TradingView.
016580 stock has risen by 1.17% compared to the previous week, the month change is a 4.82% fall, over the last year WHANIN PHARM has showed a 14.68% decrease.
016580 net income for the last quarter is 7.57 B KRW, while the quarter before that showed 6.34 B KRW of net income which accounts for 19.29% change. Track more WHANIN PHARM financial stats to get the full picture.
Today WHANIN PHARM has the market capitalization of 211.76 B, it has increased by 0.44% over the last week.
Yes, 016580 dividends are paid annually. The last dividend per share was 300.00 KRW. As of today, Dividend Yield (TTM)% is 2.16%. Tracking WHANIN PHARM dividends might help you take more informed decisions.
WHANIN PHARM dividend yield was 1.99% in 2023, and payout ratio reached 15.38%. The year before the numbers were 1.70% and 19.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 016580 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WHANIN PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 645.00 employees. See our rating of the largest employees — is WHANIN PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WHANIN PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WHANIN PHARM stock shows the sell signal. See more of WHANIN PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WHANIN PHARM EBITDA is 36.66 B KRW, and current EBITDA margin is 15.98%. See more stats in WHANIN PHARM financial statements.